Drug recall · September 21, 2022
Lisinopril 10 mg tablets recall
Why: Presence of Foreign Substance: Foreign material (metal piece) embedded in one tablet.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Lisinopril 10 mg tablets, 30-count Blister Card, Rx Only, MFG: Lupin Pharma, Baltimore, MD Repackaged by: RemedyRepack Inc, Indiana PA. Original NDC# 68180-0980-03, Repackaged NDC# 70518-0468-00
- Lots / codes
Lot # J0636336-073022, J0637605-080422, Exp. date 08/31/2023
- Quantity
- 1,699 blister cards/30 tablets each
- Company
- RemedyRepack Inc., Indiana, PA
- Distribution
- Distributed to two direct accounts in PA and AK.
- Initiated
- September 15, 2022 · Voluntary: Firm initiated
- Classified
- September 15, 2022
- Reported
- September 21, 2022
- Ended
- November 16, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Lisinopril
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.